Reduced Hepatocellular Carcinoma Risk vs Bleeding Risk Associated With Aspirin
- PMID: 31046061
- DOI: 10.1001/jamaoncol.2019.0614
Reduced Hepatocellular Carcinoma Risk vs Bleeding Risk Associated With Aspirin
Comment in
-
Reduced Hepatocellular Carcinoma Risk vs Bleeding Risk Associated With Aspirin-In Reply.JAMA Oncol. 2019 Jun 1;5(6):911-912. doi: 10.1001/jamaoncol.2019.0630. JAMA Oncol. 2019. PMID: 31046066 No abstract available.
Comment on
-
Association Between Aspirin Use and Risk of Hepatocellular Carcinoma.JAMA Oncol. 2018 Dec 1;4(12):1683-1690. doi: 10.1001/jamaoncol.2018.4154. JAMA Oncol. 2018. PMID: 30286235 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
